<code id='B1BDA69824'></code><style id='B1BDA69824'></style>
    • <acronym id='B1BDA69824'></acronym>
      <center id='B1BDA69824'><center id='B1BDA69824'><tfoot id='B1BDA69824'></tfoot></center><abbr id='B1BDA69824'><dir id='B1BDA69824'><tfoot id='B1BDA69824'></tfoot><noframes id='B1BDA69824'>

    • <optgroup id='B1BDA69824'><strike id='B1BDA69824'><sup id='B1BDA69824'></sup></strike><code id='B1BDA69824'></code></optgroup>
        1. <b id='B1BDA69824'><label id='B1BDA69824'><select id='B1BDA69824'><dt id='B1BDA69824'><span id='B1BDA69824'></span></dt></select></label></b><u id='B1BDA69824'></u>
          <i id='B1BDA69824'><strike id='B1BDA69824'><tt id='B1BDA69824'><pre id='B1BDA69824'></pre></tt></strike></i>

          explore

          explore

          author:knowledge    Page View:852
          In the dark, fingers hover over a phone with text exchange displayed on its screen
          Adobe

          Early this spring, dozens of volunteers fielding requests from people struggling with eating disorders — many of whom call amid mental health crises — received surprising and abrupt news: Their service at the National Eating Disorders Association would end within weeks.

          In their place, the nonprofit would offer an AI chatbot called Tessa.

          advertisement

          NEDA told volunteers the tool could respond faster and help more people than they could; the helpline was missing almost half of clients’ attempts to contact them, and wait times had surged to several days or even almost two weeks, according to emails reviewed by STAT.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Why failed clinical trials don’t always spell doom for a new drug
          Why failed clinical trials don’t always spell doom for a new drug

          AdobeThisarticlewasadaptedfromSTAT’slatestreport,“Failedtrial,successfuldrug:howanegativereadoutcans

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          FDA panel issues narrow recommendation for Covid vaccine booster doses

          ROBYNBECK/AFPviaGettyImagesForanarchivedversionoflivecoverageofthehearingoftheFDA’sadvisorypanel,cli